Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

NCT04020094 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped funding source withdrawn

Conditions

Prostate Adenocarcinoma

Interventions

COMBINATION_PRODUCT: MVA-BN-Brachyury

Sponsor

University of Utah

Collaborators

[object Object]
[object Object]